The nuclear imaging devices market is undergoing a technological renaissance, with hybrid systems and AI-driven analytics reshaping how clinicians diagnose and monitor disease. PET/CT, SPECT/CT, and PET/MRI scanners are becoming the standard of care, offering fused anatomical and functional images that enhance diagnostic accuracy and treatment planning. The market was valued at USD 8.27 billion...